DOP002. Molecular response to ustekinumab in moderate-to-severe Crohn’s disease by serum protein analysis: results from the UNITI-1 and UNITI-2 Phase 3 induction studies | Zendy

AI Assistant Blog Pricing

DOP002. Molecular response to ustekinumab in moderate-to-severe Crohn’s disease by serum protein analysis: results from the UNITI-1 and UNITI-2 Phase 3 induction studies

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.